Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Change in Cash (2016 - 2025)

Historic Change in Cash for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to -$190000.0.

  • Palisade Bio's Change in Cash rose 9426.5% to -$190000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year increase of 6131.74%. This contributed to the annual value of -$2.6 million for FY2024, which is 542857.14% down from last year.
  • Per Palisade Bio's latest filing, its Change in Cash stood at -$190000.0 for Q3 2025, which was up 9426.5% from -$1.8 million recorded in Q2 2025.
  • Palisade Bio's Change in Cash's 5-year high stood at $9.0 million during Q3 2022, with a 5-year trough of -$3.9 million in Q1 2022.
  • Over the past 5 years, Palisade Bio's median Change in Cash value was -$1.1 million (recorded in 2023), while the average stood at -$335375.0.
  • Per our database at Business Quant, Palisade Bio's Change in Cash plummeted by 382959.18% in 2022 and then skyrocketed by 28665.87% in 2023.
  • Over the past 5 years, Palisade Bio's Change in Cash (Quarter) stood at -$98000.0 in 2021, then crashed by 1534.69% to -$1.6 million in 2022, then crashed by 79.78% to -$2.9 million in 2023, then soared by 161.84% to $1.8 million in 2024, then plummeted by 110.67% to -$190000.0 in 2025.
  • Its Change in Cash stands at -$190000.0 for Q3 2025, versus -$1.8 million for Q2 2025 and -$2.6 million for Q1 2025.